IGFBP-3

IGFBP-3 詳細

英語名Insulin-like growth factor binding protein III市販薬剤の数0
治験薬の数2ターゲットの別称
研究&開発段階Phase 2 Clinical
英語名Insulin-like growth factor binding protein III
ターゲットの別称
市販薬剤の数0
治験薬の数2
研究&開発段階Phase 2 Clinical

IGFBP-3 製品リスト

  • 属性

    Protein (2)

  • 製品ライブラリ

    オンライン (2)

  • Human (2)

  • タグ

    His Tag (1)Fc Tag (1)

  • マーカー

    Unconjugated (2)

製品番号発現システム製品説明タンパク質の構造純度特性
IG3-H5253
Human
HEK293
Human IGFBP-3 (28-291) Protein, Fc Tag
IG3-H52H9
Human
HEK293
Human IGFBP-3 Protein, His Tag
総数量2
  • 1

IGFBP-3バックグランド

Insulin-like growth factor-binding protein 3 is also known as IGFBP3, is a protein that, in humans, is encoded by the IGFBP3 gene. IGFBP3 forms a ternary complex of about 140 ~150 kDa with IGF1 or IGF2 and a glycoprotein insulin-like growth factor acid-labile subunit (ALS), thus alter the interaction of IGFs with their cell surface receptors. IGFBP3 exerts either proapoptotic or growth stimulatory effects depending upon the cellular context. Studies have shown that IGFBP3 can leads to the induction of apoptosis dependent or independent of the IGF-IGF receptor axis, accordingly acts as a negative regulator of tumorigenesis and progressing in certain carcinomas. The highest expression level is found in the nonparanchymal cells of the liver. Expression levels are also higher during extrauterine life and peak during puberty.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Mecasermin RinfabaterhIGF-I/rhIGFBP-3; TAK-607; OHB-607; IGF-I/IGFBP-3; SHP-607; HGT-ROP-001Phase 2 ClinicalInsmedBronchopulmonary Dysplasia; Cerebral Intraventricular Hemorrhage; Failure to Thrive; Laron Syndrome; Lung Diseases; Myotonic Dystrophy; Noonan Syndrome; Retinopathy of Prematurity
詳細
ENT-001Ent-001; ENT-001; Ent001Phase 1 ClinicalOspedale San RaffaeleDiabetes Mellitus, Type 1; Inflammatory Bowel Diseases
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8